Published Erratum
doi: 10.1038/s41467-025-64919-5.
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas
April A Apfelbaum #
1
2
3
, Eric Morin #
1
2
3
4
5
, Dominik Sturm
6
7
8
9
, Georges Ayoub
10
11
, Jeromy DiGiacomo
1
2
, Sher Bahadur
1
2
, Bhavyaa Chandarana
12
13
, Phoebe C Power
1
3
, Margaret M Cusick
1
, Dana Novikov
1
2
, Prem Prabhakar
10
, Robert E Jones
10
, Jayne Vogelzang
10
, Connor C Bossi
10
, Seth Malinowski
10
, Lewis M Woodward
14
, Tania A Jones
14
, John Jeang
1
2
, Sarah W Lamson
1
2
, Jared Collins
1
2
, Kelly Y Cai
1
2
, Jacquelyn S Jones
10
, Sehee Oh
15
, Hyesung Jeon
15
16
, Jinhua Wang
15
16
, Amy Cameron
17
, Patrick Rechter
17
, Angela De Leon
1
, Karthikeyan Murugesan
18
, Meagan Montesion
18
, Lee A Albacker
18
, Shakti H Ramkissoon
19
20
21
, Cornelis M van Tilburg
7
9
22
23
, Emily C Hardin
7
9
22
23
, Philipp Sievers
22
24
25
, Felix Sahm
8
22
24
25
, Kee Kiat Yeo
1
3
, Tom Rosenberg
1
3
, Susan N Chi
1
3
, Karen D Wright
1
3
, Steven Hébert
12
, Sydney Peck
26
, Alberto Picca
27
, Valérie Larouche
28
, Samuele Renzi
29
, Sara J Buhrlage
15
16
, Tejus A Bale
30
, Amy A Smith
26
, Mehdi Touat
27
, Nada Jabado
13
, Eric S Fischer
15
16
, Michael J Eck
15
16
, Lissa Baird
1
3
31
, Olaf Witt
7
8
9
22
23
, Claudia L Kleinman
12
13
, Quang-De Nguyen
17
, Denise Sheer
14
, Sanda Alexandrescu
1
32
, David T W Jones
6
7
8
, Keith L Ligon
33
34
35
36
, Pratiti Bandopadhayay
37
38
39
Affiliations
Affiliations
- 1 Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
- 2 Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- 3 Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.
- 4 Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
- 5 Uppsala University Children's Hospital, Uppsala, Sweden.
- 6 Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
- 7 National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.
- 8 German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 9 Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
- 10 Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
- 11 Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
- 12 Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.
- 13 Department of Human Genetics, McGill University, Montreal, QC, Canada.
- 14 Blizard Institute, Queen Mary University of London, London, UK.
- 15 Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
- 16 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
- 17 Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- 18 Computational Discovery, Foundation Medicine Inc, Boston, MA, USA.
- 19 Pathology, Foundation Medicine Inc, Boston, MA, USA.
- 20 Labcorp Oncology, Durham, NC, USA.
- 21 Wake Forest Comprehensive Cancer Center and Department of Pathology, Winston-, Salem, NC, USA.
- 22 Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
- 23 Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 24 Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
- 25 CCU Neuropathology, German Consortium for Translational Cancer Research, Heidelberg, Germany, Heidelberg, Germany.
- 26 Orlando Health- Arnold Palmer Hospital for Children, Orlando, FL, USA.
- 27 Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau - Paris Brain Institute (ICM), AP-HP, Pitié Salpêtrière University Hospital, Paris, France.
- 28 Department of Pediatrics, Hemato-Oncology, CHU de Québec-Université Laval, Quebec City, QC, Canada.
- 29 Division of Pediatric Hematology-Oncology, Chul-Québec, Quebec City, QC, Canada.
- 30 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 31 Department of Neurosurgery, Harvard Medical School, Harvard University, Boston, MA, USA.
- 32 Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA.
- 33 Broad Institute of MIT and Harvard, Cambridge, MA, USA. keith_ligon@dfci.harvard.edu.
- 34 Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. keith_ligon@dfci.harvard.edu.
- 35 Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. keith_ligon@dfci.harvard.edu.
- 36 Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA. keith_ligon@dfci.harvard.edu.
- 37 Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.
- 38 Broad Institute of MIT and Harvard, Cambridge, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.
- 39 Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.
# Contributed equally.
- PMID: 41068145
- PMCID: PMC12511588
- DOI: 10.1038/s41467-025-64919-5
Item in Clipboard
Published Erratum
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas
April A Apfelbaum et al.
Nat Commun.
.
Display options
Format
doi: 10.1038/s41467-025-64919-5.
Authors
April A Apfelbaum #
1
2
3
, Eric Morin #
1
2
3
4
5
, Dominik Sturm
6
7
8
9
, Georges Ayoub
10
11
, Jeromy DiGiacomo
1
2
, Sher Bahadur
1
2
, Bhavyaa Chandarana
12
13
, Phoebe C Power
1
3
, Margaret M Cusick
1
, Dana Novikov
1
2
, Prem Prabhakar
10
, Robert E Jones
10
, Jayne Vogelzang
10
, Connor C Bossi
10
, Seth Malinowski
10
, Lewis M Woodward
14
, Tania A Jones
14
, John Jeang
1
2
, Sarah W Lamson
1
2
, Jared Collins
1
2
, Kelly Y Cai
1
2
, Jacquelyn S Jones
10
, Sehee Oh
15
, Hyesung Jeon
15
16
, Jinhua Wang
15
16
, Amy Cameron
17
, Patrick Rechter
17
, Angela De Leon
1
, Karthikeyan Murugesan
18
, Meagan Montesion
18
, Lee A Albacker
18
, Shakti H Ramkissoon
19
20
21
, Cornelis M van Tilburg
7
9
22
23
, Emily C Hardin
7
9
22
23
, Philipp Sievers
22
24
25
, Felix Sahm
8
22
24
25
, Kee Kiat Yeo
1
3
, Tom Rosenberg
1
3
, Susan N Chi
1
3
, Karen D Wright
1
3
, Steven Hébert
12
, Sydney Peck
26
, Alberto Picca
27
, Valérie Larouche
28
, Samuele Renzi
29
, Sara J Buhrlage
15
16
, Tejus A Bale
30
, Amy A Smith
26
, Mehdi Touat
27
, Nada Jabado
13
, Eric S Fischer
15
16
, Michael J Eck
15
16
, Lissa Baird
1
3
31
, Olaf Witt
7
8
9
22
23
, Claudia L Kleinman
12
13
, Quang-De Nguyen
17
, Denise Sheer
14
, Sanda Alexandrescu
1
32
, David T W Jones
6
7
8
, Keith L Ligon
33
34
35
36
, Pratiti Bandopadhayay
37
38
39
Affiliations
- 1 Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
- 2 Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- 3 Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.
- 4 Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
- 5 Uppsala University Children's Hospital, Uppsala, Sweden.
- 6 Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
- 7 National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.
- 8 German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 9 Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
- 10 Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
- 11 Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
- 12 Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.
- 13 Department of Human Genetics, McGill University, Montreal, QC, Canada.
- 14 Blizard Institute, Queen Mary University of London, London, UK.
- 15 Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
- 16 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
- 17 Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- 18 Computational Discovery, Foundation Medicine Inc, Boston, MA, USA.
- 19 Pathology, Foundation Medicine Inc, Boston, MA, USA.
- 20 Labcorp Oncology, Durham, NC, USA.
- 21 Wake Forest Comprehensive Cancer Center and Department of Pathology, Winston-, Salem, NC, USA.
- 22 Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
- 23 Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 24 Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
- 25 CCU Neuropathology, German Consortium for Translational Cancer Research, Heidelberg, Germany, Heidelberg, Germany.
- 26 Orlando Health- Arnold Palmer Hospital for Children, Orlando, FL, USA.
- 27 Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau - Paris Brain Institute (ICM), AP-HP, Pitié Salpêtrière University Hospital, Paris, France.
- 28 Department of Pediatrics, Hemato-Oncology, CHU de Québec-Université Laval, Quebec City, QC, Canada.
- 29 Division of Pediatric Hematology-Oncology, Chul-Québec, Quebec City, QC, Canada.
- 30 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 31 Department of Neurosurgery, Harvard Medical School, Harvard University, Boston, MA, USA.
- 32 Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA.
- 33 Broad Institute of MIT and Harvard, Cambridge, MA, USA. keith_ligon@dfci.harvard.edu.
- 34 Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. keith_ligon@dfci.harvard.edu.
- 35 Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. keith_ligon@dfci.harvard.edu.
- 36 Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA. keith_ligon@dfci.harvard.edu.
- 37 Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.
- 38 Broad Institute of MIT and Harvard, Cambridge, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.
- 39 Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.
# Contributed equally.
- PMID: 41068145
- PMCID: PMC12511588
- DOI: 10.1038/s41467-025-64919-5
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.Apfelbaum AA, Morin E, Sturm D, Ayoub G, DiGiacomo J, Bahadur S, Chandarana B, Power PC, Cusick MM, Novikov D, Prabhakar P, Jones RE, Vogelzang J, Bossi CC, Malinowski S, Woodward LM, Jones TA, Jeang J, Lamson SW, Collins J, Cai KY, Jones JS, Oh S, Jeon H, Wang J, Cameron A, Rechter P, De Leon A, Murugesan K, Montesion M, Albacker LA, Ramkissoon SH, van Tilburg CM, Hardin EC, Sievers P, Sahm F, Yeo KK, Rosenberg T, Chi SN, Wright KD, Hébert S, Peck S, Picca A, Larouche V, Renzi S, Buhrlage SJ, Bale TA, Smith AA, Touat M, Jabado N, Fischer ES, Eck MJ, Baird L, Witt O, Kleinman CL, Nguyen QD, Sheer D, Alexandrescu S, Jones DTW, Ligon KL, Bandopadhayay P. Apfelbaum AA, et al. Nat Commun. 2025 Jul 31;16(1):7018. doi: 10.1038/s41467-025-61820-z. Nat Commun. 2025. PMID: 40744913 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
